Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Activating signal cointegrator 1 complex subunit 3 (ASCC3) is a large, versatile Ski2-like helicase that forms the core of the activating signal cointegrator 1 complex (ASCC), a multi-protein assembly critically involved in DNA repair, gene expression modulation, and ribosome quality control[1][2][3][4]. ASCC3 unwinds nucleic acids in a 3'-to-5' direction and is essential for generating single-stranded DNA regions necessary for alkylation damage repair by the enzyme ALKBH3[2][3]. It possesses two helicase "cassettes" capable of threading both DNA and, potentially, RNA substrates. ASCC3 also participates in cellular recovery following DNA damage and regulates the expression of interferon-stimulated genes, acting as a modulator of innate immune responses[3]. Mutations, particularly those found in cancer, often target evolutionarily conserved surfaces critical for ASCC3's function and its protein-protein interactions[2][4]. No direct drug modulators or established clinical biomarkers for ASCC3 have been reported to date.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Activating signal cointegrator 1 complex subunit 3 (ASCC3).